ADVANCED/METASTATIC NSCLC
Clinical trials for ADVANCED/METASTATIC NSCLC explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC NSCLC trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Modified immune cells unleashed to fight tough lung cancers
Disease control Recruiting nowThis early-stage trial is testing a new type of cell therapy for people with advanced lung cancer that has spread and no longer responds to standard treatments. The therapy uses specially modified 'natural killer' immune cells designed to recognize and attack cancer cells that ha…
Matched conditions: ADVANCED/METASTATIC NSCLC
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Cancer treatment breakthrough? timing your therapy could be key
Disease control Recruiting nowThis study is testing whether giving standard immunotherapy in the morning versus the afternoon makes it work better for patients with advanced cancer. It will enroll 350 people with advanced lung cancer or other solid tumors who are starting immunotherapy for the first time. Par…
Matched conditions: ADVANCED/METASTATIC NSCLC
Phase: PHASE2 • Sponsor: Liza Villaruz, MD • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC